Genetic testing in screening patients with lung cancer that has been or will be removed by surgery.
Studying the genes in a patient's tumor cells may help determine the best treatment for patients that have certain genetic changes.
Lung Adenocarcinoma Lung Large Cell Carcinoma Stage IB Lung Non-Small Cell Carcinoma AJCC v7 Stage IB Lung Squamous Cell Carcinoma AJCC v7 Stage II Lung Non-Small Cell Cancer AJCC v7 Stage II Lung Squamous Cell Carcinoma AJCC v7 Stage IIA Lung Non-Small Cell Carcinoma AJCC v7 Stage IIA Lung Squamous Cell Carcinoma AJCC v7 Stage IIB Lung Non-Small Cell Carcinoma AJCC v7 Stage IIB Lung Squamous Cell Carcinoma AJCC v7 Stage IIIA Lung Non-Small Cell Cancer AJCC v7 Stage IIIA Lung Squamous Cell Carcinoma AJCC v7 Carcinoma Carcinoma, Squamous Cell Adenocarcinoma Adenocarcinoma of Lung Carcinoma, Large Cell Nivolumab Erlotinib Hydrochloride Crizotinib Clinical Observation Cytology Specimen Collection Procedure
Lead Scientists at UC Health
- Lyudmila A. Bazhenova (ucsd)
Dr. Bazhenova’s clinical practice and research concentrate on lung cancer, particularly as this relates to females and non-smokers. She actively participates in cooperative group trials, and takes an active role in designing and implementing clinical investigations, including phase II studies and correlative science projects with several UCSD investigators.
- David R. Gandara (ucdavis)
Professor, Hematology and Oncology. Authored (or co-authored) 439 research publications
- accepting new patients
- Start Date
- National Cancer Institute (NCI)
- Phase 3
- Study Type
- Last Updated